Sei Investments Co. boosted its holdings in shares of Ingevity Corporation (NYSE:NGVT – Free Report) by 42.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 153,411 shares of the company’s stock after purchasing an additional 45,409 shares during the quarter. Sei Investments Co.’s holdings in Ingevity were worth $10,927,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Global Retirement Partners LLC acquired a new stake in shares of Ingevity during the fourth quarter worth approximately $27,000. Meeder Asset Management Inc. acquired a new stake in Ingevity in the fourth quarter valued at $33,000. Geneos Wealth Management Inc. raised its holdings in Ingevity by 85.8% in the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after acquiring an additional 387 shares in the last quarter. Headlands Technologies LLC bought a new position in Ingevity during the 2nd quarter valued at $46,000. Finally, Kestra Advisory Services LLC bought a new position in Ingevity during the 4th quarter valued at $47,000. 91.59% of the stock is currently owned by hedge funds and other institutional investors.
Ingevity Price Performance
Shares of NYSE NGVT opened at $73.16 on Friday. The company has a current ratio of 1.61, a quick ratio of 0.92 and a debt-to-equity ratio of 22.52. The company has a market capitalization of $2.54 billion, a price-to-earnings ratio of 49.77 and a beta of 1.16. Ingevity Corporation has a twelve month low of $39.74 and a twelve month high of $79.29. The business has a 50 day simple moving average of $71.76 and a 200-day simple moving average of $70.97.
Insider Buying and Selling at Ingevity
In other news, SVP Terrance M. Dyer sold 496 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.88% of the company’s stock.
Analyst Upgrades and Downgrades
NGVT has been the subject of several research analyst reports. Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a research report on Friday, July 17th. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $80.00.
View Our Latest Stock Report on NGVT
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Articles
- Five stocks we like better than Ingevity
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
